tiprankstipranks
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
INM
InMed Pharmaceuticals
RESEARCH TOOLSreports
Want to see INM full AI Analyst Report?

InMed Pharmaceuticals (INM) Income Statement

388 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q2 2026), InMed Pharmaceuticals's total revenue was C$1.13M, an increase of 1.23% from the same quarter last year. In Q2, InMed Pharmaceuticals's net income was C$-2.78M. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
C$ 4.94MC$ 4.60MC$ 4.14MC$ 1.09MC$ 0.00
Gross Profit
C$ 1.71MC$ 1.10MC$ 1.40MC$ 543.55KC$ 0.00
Operating Expenses
C$ 9.62MC$ 9.24MC$ 9.78MC$ 14.34MC$ 12.17M
Depreciation and Amortization
C$ 534.73KC$ 604.52KC$ 596.00KC$ 511.79KC$ 149.84K
EBITDA
C$ -7.26MC$ -7.06MC$ -7.78MC$ -13.28MC$ -12.17M
Operating Income
C$ -7.92MC$ -8.13MC$ -8.38MC$ -13.79MC$ -12.17M
Other Income/Expenses
C$ -244.14KC$ 465.98KC$ 444.26KC$ -4.81MC$ -478.14K
Pretax Income
C$ -8.16MC$ -7.67MC$ -7.93MC$ -18.60MC$ -12.65M
Net Income
C$ -8.16MC$ -7.68MC$ -7.95MC$ -18.60MC$ -12.65M
Per Share Metrics
Basic EPS
C$ -11.44C$ -27.55C$ -86.00C$ -21.35KC$ -938.91
Diluted EPS
C$ -11.44C$ -27.55C$ -86.00C$ -21.35KC$ -938.91
Weighted Average Shares Outstanding
 975.99K 381.05K 122.42K 1.12K 13.44K
Weighted Average Shares Outstanding (Diluted)
 975.99K 381.05K 122.42K 1.12K 13.44K
Currency in CAD

InMed Pharmaceuticals Earnings and Revenue History